Thermal Preconditioning for Breast Reconstruction After Mastectomy
This study is looking at whether using a special device called Plexaa BLOOM43 to warm the breast before surgery can help improve recovery for patients having a mastectomy (surgery to remove a breast) and immediate breast reconstruction. You could be eligible if you are an adult (18 or older) having a mastectomy with planned immediate breast reconstruction at Atrium Health Wake Forest Baptist Medical Center. Patients with inflammatory breast cancer or a history of radiation to the breast/chest wall cannot join. The study aims to see how many people join, how well they follow the study plan, and how consistently doctors can identify skin flap issues after surgery. The study status is unclear, and it plans to enroll 40 participants.
- Study design
- This is a prospective, single-center, two-arm randomized study comparing two preconditioning interventions, with a separate retrospective control group. About 40 participants will be enrolled.
- What's involved
- Participants will use the Plexaa BLOOM43 device on their breast for either 1 hour (one cycle) or 3 hours (three cycles) before surgery. The study will measure outcomes for up to two weeks after surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to two weeks after surgery to assess recruitment rate, protocol adherence, and interrater reliability of mastectomy skin flap necrosis.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Thermal Preconditioning in Mastectomy Patients With Immediate Breast Reduction
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Adam Katz, MD · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Recruitment Ratethrough week 2
Percent of eligible patients who consent
- Protocol Adherence Ratethrough week 2
Percent of participants compliant with preconditioning as assigned
- Interrater Reliability of Mastectomy Skin Flap Necrosisthrough week 2
consistency of flap necrosis diagnosis across independent surgeons
- Interrater Reliability of SKIN Scorethrough week 2
consistency of SKIN score across independent surgeons
- Participant Feedback Survey Scorethrough week 2
Participants will be given an 11-item questionnaire with total score range 11-55 with lower scores indicating higher level of satisfaction.